{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:43:23Z","timestamp":1782603803804,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>\u03b1-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptors mediate excitatory neurotransmission in the brain and may be targeted by autoantibodies, leading to autoimmune synaptic encephalitis (AE). AE can be associated with other autoimmune diseases. However, the cooccurrence of anti-AMPA and NMDA receptor AE together with myasthenia gravis (MG) is unusual.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 24-year-old previously healthy male presented with seronegative ocular MG, the diagnosis of which was supported by single-fiber electrophysiology findings. Three months later, he developed AE, initially being positive for AMPA receptor antibodies and subsequently for NMDA receptor antibodies. No underlying malignancy was found. In response to aggressive immunosuppressive treatment, he recovered (modified Rankin Scale (mRS) score change from 5 to 1). Despite some cognitive problems at the 1-year follow-up, which were not revealed using the mRS, he was able to return to his studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>AE may coexist with other autoimmune disorders. Patients with seronegative MG, including ocular MG, may develop autoimmune encephalitis with more than one cell-surface antibody.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-023-03129-2","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T06:02:32Z","timestamp":1678428152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["AMPA and NMDA receptor antibody autoimmune encephalitis preceded by ocular myasthenia gravis: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Jakob","family":"Sch\u00e4fer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Br\u00f8gger","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8895-6194","authenticated-orcid":false,"given":"Kimmo","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"3129_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3389\/fneur.2019.00804","volume":"10","author":"T Blinder","year":"2019","unstructured":"Blinder T, Lewerenz J. Cerebrospinal fluid findings in patients with autoimmune encephalitis - a systematic analysis. Front Neurol. 2019;10:804.","journal-title":"Front Neurol"},{"key":"3129_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.21589","volume":"65","author":"M Lai","year":"2009","unstructured":"Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65:424\u201334.","journal-title":"Ann Neurol"},{"key":"3129_CR3","doi-asserted-by":"publisher","first-page":"e2302","DOI":"10.1212\/WNL.0000000000009239","volume":"94","author":"E Martinez-Hernandez","year":"2020","unstructured":"Martinez-Hernandez E, Guasp M, Garc\u00eda-Serra A, Maudes E, Ari\u00f1o H, Sepulveda M, et al. Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies. Neurology. 2020;94:e2302\u201310.","journal-title":"Neurology."},{"issue":"4","key":"3129_CR4","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1212\/NXI.0000000000000245","volume":"3","author":"JJ Linnoila","year":"2016","unstructured":"Linnoila JJ, Binnicker MJ, Majed M, McKeon A. CSF herpes virus and autoantibody profiles in the evaluation of encephalitis. Neurol Neuroimmunol Neuroinflamm. 2016;3(4):e245.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"3129_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378(9):840\u201351.","journal-title":"N Engl J Med"},{"key":"3129_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCrachen L, Gabilondo I, Armanqu\u00e9 T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-N-Methy-D-aspartate (NMDA) receptor encephalitis: a cohort study. Lancet Neurol. 2013;12:157\u201365.","journal-title":"Lancet Neurol"},{"issue":"12","key":"3129_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichmann AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis. Case series and analysis of the effecs of antibodies. Lancet Neurol. 2008;7(12):1091\u20138.","journal-title":"Lancet Neurol"},{"key":"3129_CR8","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","volume":"84","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, et al. Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology. 2015;84:2403\u201312.","journal-title":"Neurology."},{"key":"3129_CR9","doi-asserted-by":"publisher","unstructured":"Li X, Mao Y-T, Wu J-J, Li L-X, Chen X-J. Anti-AMPA receptor encephalitis associated with thymomatous myasthenia gravis. J Neuroimmunol. 2015;281:35\u20137. https:\/\/doi.org\/10.1016\/j.jneuroim.2015.02.011.","DOI":"10.1016\/j.jneuroim.2015.02.011"},{"key":"3129_CR10","doi-asserted-by":"publisher","unstructured":"Luo Q, Wu X, Huang W. Anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report. BMC Neurol. 2019;13;19(1):126. https:\/\/doi.org\/10.1186\/s12883-019-1358-7.","DOI":"10.1186\/s12883-019-1358-7"},{"key":"3129_CR11","doi-asserted-by":"publisher","unstructured":"Joubert B, Kerschen P, Zekeridou A, Desestret V, Rogemond V, Chaffois M-O, et al. Clinical spectrum of encephalitis associated with antibodies against the \u03b1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor. JAMA Neurol. 2015:72(10):1163\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1715.","DOI":"10.1001\/jamaneurol.2015.1715"},{"key":"3129_CR12","doi-asserted-by":"publisher","unstructured":"Dalmau J, Armangu\u00e9 T, Planagum\u00e0 J, Radosevic M, Mannara F, Leypoldt F, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019:18(11):1045\u201357. https:\/\/doi.org\/10.1016\/S1474-4422(19)30244-3.","DOI":"10.1016\/S1474-4422(19)30244-3"},{"key":"3129_CR13","doi-asserted-by":"publisher","unstructured":"Nissen MS, \u00d8rvik MS, Nilsson AC, Ryding M, Lydolph M, Blaabjerg M. NMDA-receptor encephalitis in Denmark from 2009 To 2019: a national cohort study. J Neurol. 2021. https:\/\/doi.org\/10.1007\/s00415-021-10738-9.","DOI":"10.1007\/s00415-021-10738-9"},{"key":"3129_CR14","doi-asserted-by":"publisher","unstructured":"Bost C, Chanson E, Picard G, Meyronet D, Mayeur M-E, Ducray F, et al. Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies. J Neurol. 2018;265(10):2190\u2013200. https:\/\/doi.org\/10.1007\/s00415-018-8970-0.","DOI":"10.1007\/s00415-018-8970-0"},{"key":"3129_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jnnp-2011-300411","volume":"83","author":"C Finke","year":"2012","unstructured":"Finke C, Kopp UA, Pr\u00fcss H, Dalmau J, Wandinger K-P, Ploner CJ. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2012;83:195\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3129_CR16","doi-asserted-by":"publisher","unstructured":"Muniz-Castrillo S, Vogrig A, Honnorat J. Associations between Hla and autoimmune neurological diseases with autoantibodies. Autoimmun Highlights. 2020. https:\/\/doi.org\/10.1186\/s13317-019-0124-6.","DOI":"10.1186\/s13317-019-0124-6"},{"key":"3129_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fneur.2019.01142","volume":"10","author":"J Zhao","year":"2019","unstructured":"Zhao J, Wang C, Xu X, Zhang Y, Ren H, Ren Z, et al. Coexistence of autoimmune encephalitis and other systemic autoimmune diseases. Front Neurol. 2019;10:11\u201342.","journal-title":"Front Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03129-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03129-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03129-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T06:02:43Z","timestamp":1678428163000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03129-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3129"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03129-2","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"assertion":[{"value":"4 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that the study follows the tenants of the Declaration of Helsinki. For this case report, we obtained written consent from the patient to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have obtained written consent to publish this report from the patient to communicate retrospective and anonymized data from his file regarding his admission to the Dept. of Neurology, Aalborg University Hospital, Denmark.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}